ABSTRACT
This paper provides the foundation for our sleeping/waking states approach to assessment of infant functional outcome as it relates to DHA status of the infant or the mother during pregnancy. The history of our methodology for assessing sleep and wake states and comparisons with the approaches of others have been published (1,10) The instrument that we use, the Motility Monitoring System (MMS), is described in detail herein. In addition, we provide a summary of recently published data of sleep and wake states vs. DHA status (2) and the results of sleep-wake data for infants born to women with and without gestational diabetes mellitus (GDM).
